EUVIMEDEUVIMED entdecken
Crossref

Confronting High Costs And Clinical Uncertainty: Innovative Payment Models For Gene Therapies

Caroline Horrow, Aaron S Kesselheim

Health Affairs · 01.11.2023 · 42 (11) · 1532-1540

DOI: 10.1377/hlthaff.2023.00527 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Health Affairs, erschienen am 01.11.2023. Verfasst von Caroline Horrow und 1 weiteren Autor:innen. Beteiligte Einrichtung: Caroline Horrow, Brigham and Women's Hospital, Boston, Massachusetts. Hauptthemen laut MEDLINE: Clinical Decision-Making, Health Expenditures. Die Arbeit wurde bisher 35-mal zitiert (Crossref) und nennt 9 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Clinical Decision-MakingHealth ExpendituresHumansUncertaintyCosts and Cost AnalysisBudgets

Autor:innen und Institutionen

  • Caroline Horrow, Brigham and Women's Hospital, Boston, Massachusetts.
  • Aaron S. Kesselheim (akesselheim@bwh.harvard.edu), Brigham and Women's Hospital.

Zitieren

APA

Horrow, C., & Kesselheim, A. S. (2023). Confronting High Costs And Clinical Uncertainty: Innovative Payment Models For Gene Therapies. Health Affairs, 42(11), 1532-1540. https://doi.org/10.1377/hlthaff.2023.00527

Vancouver

Horrow C, Kesselheim AS. Confronting High Costs And Clinical Uncertainty: Innovative Payment Models For Gene Therapies. Health Affairs. 2023;42(11):1532-1540. doi:10.1377/hlthaff.2023.00527

BibTeX
@article{Horrow2023,
  author = {Horrow, Caroline and Kesselheim, Aaron S},
  title = {Confronting High Costs And Clinical Uncertainty: Innovative Payment Models For Gene Therapies},
  journal = {Health Affairs},
  year = {2023},
  volume = {42},
  number = {11},
  pages = {1532--1540},
  doi = {10.1377/hlthaff.2023.00527}
}
Kostenlos starten →